Lipopolysaccharide of Helicobacter pylori was tested for its mitogenicity and for its ability to stimulate cytokine release in human peripheral blood mononuclear cells (PBMC) of healthy and H. pylori-infected blood donors. Mitogenicity in PBMC induced by H. pylori LPS was similar to that induced by Campylobacter jejuni lipopolysaccharide, but lower than that induced by Escherichia coli lipopolysaccharide in the H. pylori negative blood donor group. Furthermore, H. pylori LPS was able to induce tumour necrosis factor (TNF) interleukin 1 (IL-1) and interleukin 6 (IL-6) secretion of PBMC. Compared with the ability of C. jejuni and E. coli lipopolysaccharides to stimulate cytokine release, H. pylori lipopolysaccharide induced a significantly lower TNF and IL-1 secretion of PBMC than the other tested bacterial lipopolysaccharides. Similar amounts of IL-6 release were obtained by stimulation of PBMC with H. pylori and C. jejuni lipopolysaccharides, whereas a higher IL-6 release was measured by stimulation with E. coli lipopolysaccharide. The results of this study suggest that H. pylori lipopolysaccharide has a lower immunological activity than lipopolysaccharides of other intestinal bacteria. This is probably due to its unusual acylation and phosphorylation pattern of lipid A. 
Introduction
Colonization of gastric mucosa with the Gram-negative bacterium Helicobacter pylori leads to a generalized immune response that induces specific local and systemic antibodies [1] [2] [3] .
Correspondence to: S. Birkholz Histological investigations have demonstrated that plasma cells, T cells, macrophages, and, dependent on the inflammatory status, granulocytes take part in the inflammatory reaction of the human gastric mucosa during infection with H. pylori [4] [5] [6] . This local mucosal inflammatory reaction might be partially maintained by H. pylori antigens such as lipopolysaccharides (LPS).
LPS is an important outer membrane component of Gram-negative bacteria. It is a potent immunoregulating agent with effects on both hu-moral and cellular immune responses [7] [8] [9] . Many of the LPS-induced host responses during an infection with Gram-negative bacteria are mediated by cytokines, mainly tumour necrosis factor (TNF) and interleukin 1 (IL-1) secreted by LPS activated macrophages [10] [11] [12] [13] . The biological activities of LPS can be attributed to the lipid A portion of the molecule and there seems to be a relationship between lipid A structure and its biological activity [9, 14] .
The lipopolysaccharide of H. pylori has an unusual composition of fatty acids and an unusual phosphorylation pattern [15, 16] . This might influence the biological activity of the LPS. Recently, in comparison to Salmonella enterica, a low biological activity of H. pylori LPS was demonstrated in mice [17] . 
Materials and Methods

Bacteria strains and growth conditions
The clinical isolate H. pylori 8981 was previously described by Geis et al. [18] . C. jejuni NCTC 11369 was obtained from Public Health Laboratory Service, London, UK. Bacteria were grown in brain heart infusion broth under conditions as previously described [18] 
Isolation and purification of lipopolysaccharides
LPS was isolated from about 15 g (wet weight) of bacteria by the phenol-water extraction method [19] . It was further purified by enzymatic digestions of RNA, DNA and protein. Briefly, 20 /xg/ml of RNase and DNase (Boehringer, Mannheim, FRG) were added to the LPS-solution (7,5 mg LPS/ml water). After an incubation time for 3 h at 37°C, pronase was added (100 p.g/ml, Boehringer) and incubation was continued for 20 h at 25°C. Insoluble material was sedimented by centrifugation (10 rain, 1000 x g). The LPS in the supernatant was sedimented by ultracentrifugation (100000 Xg, 3 h, 10°C); the sediment was suspended in water, and the suspension was recentrifuged twice as described above. The final sediment was taken up in a minimum amount of water and lyophilized. The LPS was suspended in sterile water to a final concentration of 2.5 mg/ml. No DNA was detected by absorbance scans (A350-A200) , and the protein content was less than 1% (w/w) of lyophilized LPS. Also silver-staining of sodium dodecyl sulphate (SDS)-polyacrylamide gels did not show any protein bands. The final LPS-solution was neutralized with 5% triethylamine (pH 7.0) to increase the solubility of LPS [20] .
Blood donors
Peripheral blood samples were obtained from healthy blood donors (laboratory staff) who had no antibodies against H. pylori as determined by immunoblot analysis and enzyme immunoassays with bacterial sonicate [21, 22] . The infections with H. pylori in patients were diagnosed by a rapid urease test from biopsy specimens of antral mucosa and by the determination of the presence of antibodies against H. pylori in the patients' sera by the methods mentioned above.
Cell isolation
PBMC were isolated by Ficoll hypaque gradient centrifugation [23] and were cultured in RPMI 1640 containing 10% inactivated human AB serum, penicillin/streptomycin and 2 mM Lglutamine. 
Lymphocyte proliferation test
Induction of cytokine production
Mononuclear cells (2 × 105 cells/well) were stimulated with LPS at various concentrations for 18 h (37°C, 5% CO 2) or incubated with medium alone. Supernatants of the quadruplicate cultures were combined and stored at -20°C.
Assay for TNF activity
For the bioassay of TNF-release, a WEHI 3 cell line sensitive for both TNF a and /3 was cultured in RPMI 1640 containing L-glutamine, antibiotics and 10% fetal calf serum (FCS). 2 × 104 cells (plated in triplicate) were incubated with ten-fold dilutions of supernatants for 20 h at 37°C [24] . Then 10 /xl of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide at a concentration of 5 mg/ml in PBS) was added to each well. After 4 h, cells were lysed by the addition of 10% SDS in 0.01 N HC1 and were incubated for 18 h. Plates were read in an ELISA 319 reader using a test wavelength of 550 nm and a reference wavelength of 690 nm. Percentage of dead target cells was determined as:
OD Probe % dead cells = 100
x 100
ODMedium Supernatants were also tested for TNF-a in a commercial enzyme immunoassay (Innogenetics, Antwerp, Belgium).
Assay for IL-6 activity
IL-6-dependent mouse hybridoma cell line B13.29 cells were cultured in RPMI 1640 containing e-glutamine, antibiotics, 10% FCS and 20 U/ml human recombinant IL-6 (Boehringer). For the assay of IL-6 activity, appropriate sample dilutions were made in B13.29 medium, lacking IL-6 as previously described [25] . Diluted samples were incubated with 5 × 103 B13.29 cells/well in B13.29 medium without IL-6 for 72 h. For the last 4 h 10 /xl MTT was added to each well and the test was further developed as described in the TNF assay. The mean of triplicate cultures was determined and biological activity was calculated by means of the IL-6 standard curve.
Assay for IL-la activity
The IL-la content of the cell supernatants was tested in a commercial enzyme immunoassay (Immunotech, Marseille, France) specific for IL-la. The stimulation index (SI) was determined for each blood donor by subtraction of the spontaneous counts (mean of triplicate cultures) from the LPS stimulated culture counts (mean of triplicate cultures) divided through the spontaneous counts. SI > 2 was defined as stimulation of the DNA synthesis. S.E. = standard error, n = number of different blood donors. 320 
Statistical methods
The significance of the differences between the various kinds of LPS were evaluated using the paired Student's t-test. Comparisons of the H.
pylori-negative group with the H. pylori-positive group were performed using the Student's t-test for unpaired data. --mean value. Statistical analysis between E. coli LPS, C. jejuni LPS and H. pylori LPS: P < 0.001, P < 0.001, P < 0.01 for 100, 10 and 1 ng/ml E, coli LPS, and P<0.005, P = 0.1, P < 0.05 for 100, 10, and 1 ng/ml C. jejuni LPS.
Results
Mitogenicity of uarious LPS on human PBMC
LPS and P_< 0.005-0.1 for C. jejuni LPS) as shown in Fig. 1 The individual values of IL-6 secreted by unstimulated PBMC were subtracted from each value of PBMC from the same blood donor which had been stimulated with LPS. The mean+S.E, of IL-6 release by unstimulated PBMC was 1872+835 for H. pylori negative blood donors (n = 6) and 1177 + 751 for H. pylori positive blood donors (n = 7).
induced a lower amount of TNF-a release than the LPS of the other bacteria tested. IL-6 release by PBMC was induced by all LPS samples tested ( coli LPS P < 0.05, H. pylori LPS P < 0.05, and C. jejuni LPS P < 0.005). TNF and IL-6 release induced by H. pylori was drastically reduced by the antibiotic Polymyxin B (10 lzg/ml), a specific LPS inhibitor [26, 27] , whereas the cytokine release induced by a purified urease-preparation was not influenced by Polymyxin B (data not shown).
LPS of H. pylori was also able to induce the secretion of IL-la as shown in Table 4 . There was a significantly lower IL-la secretion by PBMC stimulated with H. pylori LPS as compared to the stimulation capacity of E. coil and C. jejuni LPS (P < 0.05 for E. coli LPS, P < 0.005 for C. jejuni LPS). PBMC of H. pylori-positive blood donors, which had been stimulated with LPS, secreted a higher amount of IL-la than LPS-stimulated PBMC of H. pylori-negative blood donors (P < 0.05 for E. coli LPS at 100 ng/ml, Table 4 Interleukin-la release from PBMC stimulated with LPS IL-la (pg/ml) E. coli LPS (ng/ml) H. pylori LPS (ng/ml) C. jejuni LPS (ng/ml) Values are expressed as mean of three different blood donors.
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and P < 0.05 for 10 and 100 ng/ml C. jejuni LPS and H. pylori LPS).
Discussion
LPS has been described as a mitogen of murine lymphocytes [8, 28] . Some authors have also found stimulation of DNA synthesis in human lymphocytes by LPS [29, 30] . Our study shows that the DNA synthesis of PBMC from about 50% of the tested blood donors was stimulated by LPS. Only the results of these responder PBMC were evaluated. DNA synthesis of human PBMC was stimulated by H. pylori LPS as well as by E. coli and C. jejuni LPS. E. coli LPS seems to be a more potent mitogen in the H. pylori-negative blood donor group than H. pylori and C. jejuni LPS. This tendency was not seen in the H. pylori-positive blood donor group. Using commercially available purified E. coli O55:B5 LPS, DNA synthesis could also be stimulated in responder PBMC (data not shown), suggesting that the effect of our purified LPS from different species was not due to other mitogenic substances in these LPS preparations.
Recently it has been shown that macrophages isolated from healthy blood donors secreted TNF and IL-1 following stimulation by H. pylori LPS [31] . The multifunctional cytokines TNF, IL-1 and IL-6 are not only produced by macrophages but also by T cells, in the case of IL-1 and IL-6 by B cells and other kinds of cells [32] . Therefore, PBMC were chosen to measure cytokine release caused by LPS stimulation. Our study demonstrates that H. pylori LPS is able to induce the release of the inflammatory mediators TNF, ILla as well as IL-6 from PBMC of both healthy blood donors and H. pylori-infected patients.
Crabtree et al. [33] detected a higher amount of TNF-a and IL-6 in culture supernatants of gastric mucosal biopsies from H. pylori-infected patients than in those from uninfected control persons. These results point to an inflammatory reaction in the gastric mucosa; however there is no indication of the participation of H. pylori in cytokine release. Furthermore, TNF-a release was also induced by formalin-inactivated bacteria of H.
pylori [34] , suggesting the participation of membrane-bound LPS in stimulation of cytokine secretion.
In comparison with the capability of C. jejuni and E. coli LPS to induce TNF and IL-la secretion, H. pylori LPS showed a significantly lower induction of TNF and IL-la secreted by human PBMC. The results of the ELISA-assay for TNF-a confirmed those of the bioassay, suggesting that the main activity measured in the bioassay was attributed to TNF-a rather than to TNF-/3 or other lymphotoxins that could interfere in the bioassay.
TNF and IL-1 are described as potent inducers of IL-6 [32] ; therefore, it is not surprising that H. pylori LPS induces IL-6 secretion, but there was no direct correlation between the amount of IL-la secreted and the amounts of TNF or IL-6.
The IL-6 inducing capacity of C. jejuni and H. pylori LPS was similar although they differed in IL-la and TNF induction. There was a tendency for E. coli LPS to stimulate a greater IL-6 release than H. pylori LPS. The inhibition of the TNF and IL-6 release with Polymyxin B is additional evidence that no substance other than LPS was responsible for the cytokine release.
Similar results indicating the low biological activity of H. pylori LPS have been obtained in the mouse system. H. pylori LPS seemed to fail to stimulate the DNA synthesis of murine spleen lymphocytes, whereas E. coli and C. jejuni LPS had a stimulatory effect [35] . Secretion of IL-6 and TNF by murine peritoneal macrophages was also less pronounced after stimulation with H.
pylori LPS compared to stimulation with C. jejuni and Salmonella abortus-equi LPS [35] . The observed low biological activity of H. pylori LPS was also found by testing its lethal toxicity in mice. In that study, the mitogenicity and pyrogenicity were also reduced compared with those of enterobacterial lipopolysaccharide [17] . Previous studies have shown that there is a structure-function relationship of LPS. Lipid A is the biologically active part of the LPS molecule. Its structure, namely the number of fatty acids within the lipid A, their position, probable chain length, and the phosphate content appear to be critical determinants of the capacity of LPS to induce biological activities such as lethal toxicity or cytokine induction [9, 14, 36, 37] . Recently, H. pylori LPS has been chemically characterized.
The lipid A portion shows an unusual composition of fatty acids, namely 3-hydroxy palmitic acid, 3-hydroxy stearic acid and stearic acid [15, 16] . In addition to the uncommonly long 3-hydroxy fatty acids, an unusual phosphorylation pattern was detected. The 4'-phosphate seems to be absent in H. pylori lipid A [16] . Taking into account all these observations, the unusual structure of H. pylori lipid A might explain the reduced cytokine induction by H. pylori LPS compared to E. coli and C. jejuni LPS.
Another striking fact was the increase of IL-hx and IL-6 release by LPS stimulation of PBMC in the group of H. pylori-infected patients. This increase could not be correlated with H. pylori LPS as stimulant as it was independent of the origin of the LPS tested. A possible explanation for the enhanced IL-la and IL-6 secretion would be an increase in the number of IL-1 and IL-6 secreting cells. This hypothesis is supported by a previous study. When monocytes/macrophages were stimulated whith E. coli LPS, Ogawa et al. [38] detected an increase of TNF-a and IL-6 secreting cells in PBMC from patients infected with Mycobacterium tuberculosis. Unlike that study, the TNF-secretion of PBMC stimulated with LPS was not increased in H. pylori-infected patients of this study.
Our results demonstrate a low biological activity of H. pylori LPS on human PBMC of healthy and H. pylori-infected blood donors. Low or even no biological activity of LPS has also been described for the phototrophic bacteria Rhodobacter capsulatus and R. sphaeroides which are not pathogenic for humans. These LPS are non-toxic and fail to induce TNF release [37, 39] . R. capsulatus LPS induces IL-1 or IL-6 activity only poorly [37] . Comparing these data with the results of H. pylori LPS, it cannot be excluded that the remain-•ng activity of H. pylori LPS takes part in the inflammatory process of the human gastric mucosa by stimulating cytokine release.
